Exercise management in type 1 diabetes: a consensus statement

Slides:



Advertisements
Similar presentations
MANAGING MDI AND EXERCISE FOR TYPE 1 DIABETES 1 S. Roberts Structured Education - Staying Ahead of the Game.
Advertisements

Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive Featured Article: Carmel.
Diabetes Update: Michael Gottschalk, M.D, Ph.D.
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial  Dr.
Volume 384, Issue 9961, Pages (December 2014)
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes.
Volume 11, Issue 5, Pages (May 2012)
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive.
BMI and risk of dementia in two million people over two decades: a retrospective cohort study  Dr Nawab Qizilbash, MRCP, John Gregson, PhD, Michelle E.
Volume 359, Issue 9322, Pages (June 2002)
Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta- analysis  Kirstine J Bell, BNutrDiet, Alan W Barclay, PhD, Peter Petocz,
From: Effect of a Low-Carbohydrate Diet on Appetite, Blood Glucose Levels, and Insulin Resistance in Obese Patients with Type 2 Diabetes Ann Intern Med.
Volume 10, Issue 12, Pages (December 2011)
Fetal growth and ethnic variation
Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study 
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled.
Volume 379, Issue 9824, Pages (April 2012)
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Abdominal lipohypertrophy without insulin injection
Volume 371, Issue 9611, Pages (February 2008)
Volume 12, Issue 1, Pages (January 2013)
Volume 9, Issue 5, Pages (May 2008)
Volume 366, Issue 9482, Pages (July 2005)
Insulin affordability
Pralidoxime for organophosphate poisoning
21st century diabetes care: a marriage between humans and technology
George Dailey, MD  Mayo Clinic Proceedings 
Volume 379, Issue 9811, Pages (January 2012)
Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel- group trial  Hood Thabit, PhD, Sara Hartnell, BSc, Janet M Allen,
Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study 
Aspirin in the prevention of cancer – Author's reply
Volume 366, Issue 9482, Pages (July 2005)
Volume 375, Issue 9716, Pages (February 2010)
Non-uraemic calciphylaxis with acral necrosis
Volume 2, Issue 6, Pages (June 2015)
Volume 4, Issue 2, Pages (February 2017)
The effect of explosive remnants of war on global public health: a systematic mixed- studies review using narrative synthesis  Alexandra Frost, MSc, Prof.
Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study  William.
Volume 379, Issue 9835, Pages (June 2012)
Volume 375, Issue 9732, Pages (June 2010)
Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis  Ulla Beijer, PhD, Achim Wolf, MSc, Dr.
Prediabetes in youths: mechanisms and biomarkers
Cold water immersion: sudden death and prolonged survival
Modern strategies for management of glycaemia in type 1 diabetes
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled.
Volume 380, Issue 9836, Pages (July 2012)
Diabetic Ketoacidosis and Acute Mountain Sickness: Case Report and Review of Treatment Options in Type 1 Diabetes Mellitus  Steven C.M. Miller, BSc, MBChB,
Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall.
Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England.
Volume 372, Issue 9647, Pages (October 2008)
Volume 377, Issue 9764, Pages (February 2011)
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Is Growth Hormone Resistance/IGF-1 Reduction Good for You?
Volume 381, Issue 9880, Pages (May 2013)
Volume 3, Issue 9, Pages e431-e440 (September 2016)
Volume 5, Issue 4, Pages (April 2018)
Low-technology approaches
The emotional journey of gestational diabetes
Volume 375, Issue 9714, Pages (February 2010)
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial  Dr David Preiss, PhD, Suzanne M Lloyd,
Prescription for change
Vitamin D status and ill health – Author's reply
What is type 2 diabetes? Medicine
Fetal growth and ethnic variation
Volume 393, Issue 10177, Pages (March 2019)
Volume 5, Issue 1, Pages (January 2018)
Use of standardised patients to assess gender differences in quality of tuberculosis care in urban India: a two-city, cross-sectional study  Benjamin.
Volume 371, Issue 9611, Pages (February 2008)
Reversible biological adaptations in obesity
Presentation transcript:

Exercise management in type 1 diabetes: a consensus statement Prof Michael C Riddell, PhD, Ian W Gallen, FRCP, Carmel E Smart, PhD, Craig E Taplin, FRACP, Peter Adolfsson, MD, Alistair N Lumb, MRCP, Aaron Kowalski, PhD, Prof Remi Rabasa-Lhoret, MD, Prof Rory J McCrimmon, MD, Carin Hume, MSc, Francesca Annan, MSc, Paul A Fournier, PhD, Claudia Graham, PhD, Bruce Bode, MD, Prof Pietro Galassetti, MD, Prof Timothy W Jones, FRACP, Iñigo San Millán, PhD, Tim Heise, MD, Anne L Peters, MD, Andreas Petz, BEd, Lori M Laffel, MD  The Lancet Diabetes & Endocrinology  Volume 5, Issue 5, Pages 377-390 (May 2017) DOI: 10.1016/S2213-8587(17)30014-1 Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 1 Variability in blood glucose responses to different forms of exercise in people with type 1 diabetes High individual variability exists in the blood glucose responses to different form of exercise, as denoted by the arrows and grey shading. In general, aerobic exercise decreases glycaemia, anaerobic exercise increases glycaemia, and mixed activities are associated with glucose stability. Individual responses are dependent on various additional factors, including the duration and intensity of the activity, initial blood glucose concentrations, individual fitness, concentrations of insulin, glucagon, and other counter-regulatory hormones in the circulation, and the nutritional status of the individual. The Lancet Diabetes & Endocrinology 2017 5, 377-390DOI: (10.1016/S2213-8587(17)30014-1) Copyright © 2017 Elsevier Ltd Terms and Conditions

Figure 2 Decision tree for aerobic exercise and mixed aerobic and anaerobic activities lasting 30 min or longer in people with type 1 diabetes This decision tree can serve as a starting point for individuals with type 1 diabetes planning to do aerobic exercise. CSII=continuous subcutaneous insulin infusion. *Mixed activities that include anaerobic bursts of exercise might require a lower carbohydrate intake or less insulin dose reductions than continuous moderate aerobic activities. †If both resistance and aerobic exercise are to be done, resistance exercise could be done first to help attenuate hypoglycaemia. ‡In some situations, such as Nordic skiing, marathon running, or prolonged cycling and trekking, increased carbohydrate feeding rather than insulin dose reduction might help improve endurance performance in prolonged activities. In other situations, both bolus and basal insulin dose reductions might be needed to help restrict or reduce carbohydrate intake. Continuous glucose monitoring could be considered where patient or parent preference dictates, or in individuals with a history of nocturnal or severe hypoglycaemia. The Lancet Diabetes & Endocrinology 2017 5, 377-390DOI: (10.1016/S2213-8587(17)30014-1) Copyright © 2017 Elsevier Ltd Terms and Conditions